RAC 0.29% $1.71 race oncology ltd

Biotech cycle, just getting started?Beyond Borders report -...

  1. 2,794 Posts.
    lightbulb Created with Sketch. 2857
    Biotech cycle, just getting started?

    Beyond Borders report - worth a read https://www.ey.com/en_us/life-sciences/biotech-outlook

    https://hotcopper.com.au/data/attachments/6340/6340318-24f89f58b6ddcc63dcc9ef99b788a286.jpg

    https://www.pharmaceutical-technology.com/analyst-comment/biotech-increase-q1-venture-funding/https://hotcopper.com.au/data/attachments/6340/6340288-3026bb811b77a10e35919ae573f5e5e5.jpg
    Deal pipeline turning positive


    https://hotcopper.com.au/data/attachments/6340/6340296-c08ad52f586584a8916bf9dc78dc5080.jpg
    NBI breakout, change in trend
    https://hotcopper.com.au/data/attachments/6340/6340300-b6fe1cc234a5b9d4f3e8db1b41a23503.jpg
    Interest rates peaking
    https://www.macrobusiness.com.au/2023/08/why-australian-interest-rates-could-still-rise/
    https://hotcopper.com.au/data/attachments/6340/6340304-41e9411ab0dbc10c8bf777bc7aee9ced.jpg
    https://www.rba.gov.au/speeches/2024/sp-so-2024-02-13.html

    Cost of living and mortgage stress will continue to feel the pain unfortunately. I would assume it may limit but not prevent the cyclical turnaround of the biotech sector in 2024 / 2025.

    If a bull run happens in 2025 it could surpass Covid rally, why? Because Covid was the spark to cash up the development pipeline for biotech. A couple of years on the cream is rising to the top!

    DYOR
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.